Literature DB >> 14584634

Psychometric properties of the PTSD Checklist-Civilian Version.

Kenneth J Ruggiero1, Kevin Del Ben, Joseph R Scotti, Aline E Rabalais.   

Abstract

We examined the psychometric properties of the PTSD Checklist (PCL), a self-report instrument designed to assess symptoms of posttraumatic stress disorder. Three hundred ninety-two participants recruited in a university setting completed the PCL in addition to several well-established self-report instruments designed to assess various forms of psychopathology (e.g., depression, general anxiety, PTSD). Ninety participants returned for readministration of selected measures. Findings provided support for psychometric properties of the PCL, including internal consistency, test-retest reliability, convergent validity, and discriminant validity. Additional strengths of the PCL are discussed.

Entities:  

Mesh：

Year:  2003        PMID： 14584634     DOI： 10.1023/A:1025714729117

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN： 0894-9867


  306 in total

1.  Trajectories of cannabis use beginning in adolescence associated with symptoms of posttraumatic stress disorder in the mid-thirties.

Authors:  Jung Yeon Lee; Judith S Brook; Stephen J Finch; David W Brook
Journal:  Subst Abus       Date:  2017-09-15       Impact factor: 3.716

2.  Extending Findings of a Relation between Posttraumatic Stress Disorder and Emotion Dysregulation among African American Individuals: A Preliminary Examination of the Moderating Role of Gender.

Authors:  Nicole H Weiss; Matthew T Tull; Katherine L Dixon-Gordon; Kim L Gratz
Journal:  J Trauma Stress Disord Treat       Date:  2013-12-06

3.  The Helpseeking Experiences of Men Who Sustain Intimate Partner Violence: An Overlooked Population and Implications for Practice.

Authors:  Emily M Douglas; Denise A Hines
Journal:  J Fam Violence       Date:  2011-08

Review 4.  Self-report measures to identify post traumatic stress disorder and/or mild traumatic brain injury and associated symptoms in military veterans of Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF).

Authors:  Lisa M Betthauser; Nazanin Bahraini; Maxine H Krengel; Lisa A Brenner
Journal:  Neuropsychol Rev       Date:  2012-02-19       Impact factor: 7.444

5.  The role of beliefs in the relationship between health problems and posttraumatic stress in adolescent and young adult cancer survivors.

Authors:  Lisa A Schwartz; Anne E Kazak; Branlyn W Derosa; Matthew C Hocking; Wendy L Hobbie; Jill P Ginsberg
Journal:  J Clin Psychol Med Settings       Date:  2012-06

6.  Victim Alcohol Intoxication During a Sexual Assault: Relations With Subsequent PTSD Symptoms.

Authors:  Anna E Jaffe; Anne L Steel; David DiLillo; Lesa Hoffman; Kim L Gratz; Terri L Messman-Moore
Journal:  Violence Vict       Date:  2017-05-17

7.  Impact of intimate partner violence on clinic attendance, viral suppression and CD4 cell count of women living with HIV in an urban clinic setting.

Authors:  Jocelyn C Anderson; Jacquelyn C Campbell; Nancy E Glass; Michele R Decker; Nancy Perrin; Jason Farley
Journal:  AIDS Care       Date:  2018-04

8.  Prevalence and correlates of probable depression and post-traumatic stress disorder among female sex workers in Lilongwe, Malawi.

Authors:  Sarah A MacLean; Kathryn E Lancaster; Thandie Lungu; Pearson Mmodzi; Mina C Hosseinipour; Brian W Pence; Bradley N Gaynes; Irving F Hoffman; William C Miller
Journal:  Int J Ment Health Addict       Date:  2017-11-14       Impact factor: 3.836

9.  Partner accommodation in posttraumatic stress disorder: initial testing of the Significant Others' Responses to Trauma Scale (SORTS).

Authors:  Steffany J Fredman; Valerie Vorstenbosch; Anne C Wagner; Alexandra Macdonald; Candice M Monson
Journal:  J Anxiety Disord       Date:  2014-04-13

10.  Posttraumatic Symptom Reporting and Reported Cigarette Smoking During Pregnancy.

Authors:  Sara L Kornfield; Marian Moseley; Dina Appleby; Courtney L McMickens; Mary D Sammel; C Neill Epperson
Journal:  J Womens Health (Larchmt)       Date:  2017-02-21       Impact factor: 2.681
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.